The insulin dosage market size in Croatia displayed fluctuations from 2013 to 2023, with a peak in 2021 at 91.865 million USD and a slight increase to 84.861 million USD in 2023. Notably, the market witnessed significant growth in 2018 with a 15.63% increase. However, the CAGR from 2019 to 2023 was nearly stagnant at -0.044%, reflecting minimal growth during these years. The years 2020 and 2021 experienced positive momentum, but this was offset by declines in 2022, followed by slight recovery in 2023 with a 0.79% increase year-on-year.
Future trends to watch for:
- Potential market stabilization as regulatory environments and healthcare innovations adapt.
- The development of advanced insulin delivery systems and their impact on market growth.
- Emerging market dynamics due to demographic shifts and changing healthcare policies.
How does Croatia rank in Insulin in Dosage Market Size Value?
| # | 24 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 China | 5,142,200,000 | 2023 | +4.22% | +3.16% | View data |
| 2 | 2 Germany | 2,490,600,000 | 2023 | -2.64% | -0.27% | View data |
| 3 | 3 United Kingdom | 1,864,000,000 | 2023 | +0.081% | +0.91% | View data |
| 4 | 4 Canada | 1,369,700,000 | 2023 | +1.89% | +2.55% | View data |
| 5 | 5 Japan | 1,340,600,000 | 2023 | -14.34% | -8.01% | View data |
| 15 | 15 Sweden | 179,060,000 | 2023 | -4.06% | -5.88% | View data |
| 16 | 16 Austria | 97,906,000 | 2023 | +0.53% | +0.26% | View data |
| 17 | 17 Croatia | 84,861,000 | 2023 | +0.79% | -0.044% | |
| 18 | 18 New Zealand | 81,840,000 | 2023 | +5.78% | +2.26% | View data |
| 19 | 19 Slovakia | 72,785,000 | 2023 | -0.13% | +0.52% | View data |
